Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626596 · ClinicalTrials.gov registry record · Phase 3
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
A Phase 3 study, sponsored by Organon and.
- Completed
- Registry status
- Phase 3
- Development phase
- 498
- Enrollment target
NCT04626596 is a Phase 3 study that has completed, run by Organon and. The registered enrollment target is 498 participants.
The verdict
NCT04626596, a Phase 3 study, has completed, sponsored by Organon and.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 498 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to confirm available evidence suggesting that the ENG implant remains highly effective when used up to 5 years.
Interventions
- COMBINATION_PRODUCT Radiopaque Etonogestrel (ENG) Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2024-12-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04626596
The ClinicalTrials.gov registry entry for NCT04626596 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organon and, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiopaque Etonogestrel (ENG) Implant is the first listed.
NCT04626596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04626596 about?
NCT04626596 is a clinical study titled "A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)". The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to...
What is the current status of trial NCT04626596?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 498 participants. The study started on 2020-11-19. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT04626596?
The interventions under investigation include: Radiopaque Etonogestrel (ENG) Implant (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04626596?
This trial is sponsored by Organon and, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.